A detailed history of Tyche Wealth Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 17,986 shares of ABBV stock, worth $3.18 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
17,986
Previous 17,952 0.19%
Holding current value
$3.18 Million
Previous $3.08 Billion 15.35%
% of portfolio
0.8%
Previous 0.75%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $5,570 - $6,777
34 Added 0.19%
17,986 $3.55 Billion
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $539,907 - $630,490
3,488 Added 24.12%
17,952 $3.08 Billion
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $50,822 - $57,907
318 Added 2.25%
14,464 $2.63 Billion
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $1.95 Million - $2.19 Million
14,146 New
14,146 $2.19 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tyche Wealth Partners LLC Portfolio

Follow Tyche Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyche Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tyche Wealth Partners LLC with notifications on news.